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A Role for FADD in T Cell
Activation and Development
not all conditions (Nagata and Golstein, 1995), but it can
also provide a survival signal (Rathmell et al., 1996). On
the other hand, CD28 has a major role in providing a
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helper signal to T cells, and yet it can also facilitate the*Department of Biology and the Cancer Center
induction of apoptosis in late-stage developing thymo-The University of California, San Diego
cytes (Punt et al., 1994; Kishimoto and Sprent, 1997).La Jolla, California 92093±0687
A particularly vexing problem has been identification²Department of Pathology
of the molecules essential in mediating the apoptosisUniversity of Michigan Medical School
in the thymus that is associated with antigen-inducedAnn Arbor, Michigan 48109
negative selection. In part, the problem is to design a
model experimental approach that reflectsphysiological
antigen-mediated deletion (Page et al., 1998). DependingSummary
on the experimental design, CD30 (Amakawa et al.,
1996), CD40-ligand (Foy et al., 1995), or CD95 (CastroFADD is a cytoplasmic adapter molecule that links the
et al., 1996) can be shown to play a role in negativefamily of death receptors to the activation of caspases
selection. Thus far there is no consensus concerning aduring apoptosis. We have produced transgenic mice
coreceptor involved in negative selection.expressing a dominantly interfering mutant of FADD,
Candidates for the receptors that could mediate thy-lacking the caspase-dimerizing death effector do-
mocyte cell death include members of the tumor necro-main, as well as mice overexpressing the poxvirus
sis factor (TNF) receptor family: CD95, TNFRI, DR3, DR4,serpin, CrmA, an inhibitor of caspases downstream of
and DR5 (Tewari and Dixit, 1996; Darnay and Aggarwal,FADD. While thymocytes from either line of mice were
1997; Yuan, 1997), some of which contain cytoplasmiccompletely protected from CD95-dependent cytotox-
ªdeath domainsº (Kitson et al., 1996; Bodmer et al., 1997;icity, neither transgene afforded protection from apo-
Pan et al., 1997). Trimerization of these moleculesptosis induced during thymocyte selection and neither
through TNF-family ligand binding causes the associa-led to the lymphoproliferative disorders associated
tion of cytoplasmic death domain±containing proteinswith deficiencies in CD95. However, in FADD dominant
and assembly of the death-inducing signal complexnegative (FADDdd) mice, early thymocyte develop-
(Kischkel et al., 1995; Boldin et al., 1996; Muzio et al.,ment was retarded and peripheral lymphocyte pools
1996; Nagata, 1997), as well as other proteins involvedwere devoid of normal populations of T cells. We show
in signal transduction.that thymocytes and peripheral T cells from FADDdd
One of the cytoplasmic molecules that appears to bedisplay signaling anomalies, implying that FADD plays
essential for apoptosis mediated by CD95, TNFRI, anda previously uncharacterized role in T cell develop-
DR3 is the cytoplasmic molecule FADD/MORT1, a Fas-ment and activation.
associating protein with a novel death domain (Boldin
et al., 1995; Chinnaiyan et al., 1995; Kischkel et al., 1995;
Baker and Reddy, 1996; Boldin et al., 1996; Hsu et al.,Introduction
1996; Varfolomeev et al., 1996; Zhang and Winoto, 1996).
Overexpression of FADD can cause apoptosis, and thisThe process of self versus nonself discrimination in the
apoptosis can be inhibited by CrmA, the poxvirus inhibi-immune system occurs both in the development of T
tor of the caspase-1 and caspase-8 molecules (Chinnai-and B cells and the formation of an antigen-naive reper-
yan et al., 1996). In addition to a death domain, FADDtoire, as well as in the maturation of lymphocytes that
contains a death effector domain, and studies haveundergo either antigen-induced activation, anergy, or
shown that mutant FADD encoding the death domaincell death. These processes depend on signaling through
alone can act as a dominant interfering inhibitor of deathantigen receptors and, importantly, several different co-
mediated by Fas ligand or TNF, whereas the death ef-receptors. A number of coreceptors have been charac-
fector domain can mediate apoptosis (Chinnaiyan et al.,terized, and initially they appeared to have distinct func-
1996).tions. Some provided a survival or helper signal; some
To determine whether signaling mediated by FADDwere found to be inhibitory to cellular activation; and
plays a role in thymic negative selection, we expressedsome overtly promoted apoptosis. As work in the field
the FADD death domain (FADDdd) in transgenic micehas progressed, studies now indicate that these core-
under control of the proximal promoter of p56lck (Chaffinceptors do not provide a single function to the cell, but
et al., 1990). For comparison, we produced transgenicrather, the effect of their signaling is multifaceted and
mice that express CrmA, the bovine poxvirus serpin-depends on cell type, activation status, and location in
like molecule that can inhibit the activity of caspases-1the cell cycle. For example, cross-linking of CD95 (Fas/
and -8. T cells and thymocytes from these mice wereApo-1) is known to induce apoptosis under some but
insensitive to killing through CD95 cross-linking, show-
ing that both transgenes were effective, although no lpr-³Present address: Department of Molecular Oncology, Genentech,
like lymphoproliferative disease was evident in mice upSouth San Francisco, California 94080.
to 1.5 yr of age. In FADDdd but not CrmA mice, thymic§To whom correspondence should be addressed (e-mail: shedrick
@ucsd.edu). development was retarded, a feature most evident by
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the small number of mature T cells in homozygous
FADDdd transgenic mice. Neither FADDdd nor CrmA
mice showed a defect in thymic negative selection, indi-
cating that signaling through FADD is not essential for
the induction of cell death; however, thymic T cells from
FADDdd-transgenic mice were defective in activation
through the T cell receptor (TCR) and CD28. These re-
sults suggest that there is a necessary signal for T cell
development and activation that is transmitted through
FADD or a molecule that binds to FADDdd.
Results
Transgenic Mice Expressing the Human
FADDdd or Pox Virus CrmA
To inhibit the function of death domain±containing recep-
tors that signal through FADD and caspase-8, two types
of transgenic mice were produced. One set of transgenic
lines was made to express the human FADDdd. This con-
struct, which includes an AU1 epitope tag, was pre-
viously shown in transfection experiments to block apo-
ptosis in both human and mouse cells (Chinnaiyan et
al., 1996). A second set of lines was made to express
the CrmA serpin-like protein encoded by bovine poxvi-
rus. This protein serves as a competitive inhibitor of
caspase-1 (Ray et al., 1992)± and caspase-8 (Muzio et
al., 1996)±mediated cell death and protease activity
(Komiyama et al., 1994), and it has also been shown to
inhibit CD95-mediated cell death (Enari et al., 1995).
During the course of these experiments transgenic mice
expressing CrmA under control of the human CD2 pro-
moter were described and shown to lack a defect in
negative selection mediated by endogenous superanti- Figure 1. Production of p1017-FADDdd and p1017-CrmA Mice
gens (Smith et al., 1996). (A) The FADDdd and CrmA constructs. CrmA and FADDdd inserts
were cloned into the p1017 transgenic vector, flanked by the murineThe cDNA coding sequences from the two different
lck proximal promoter and the entire human growth hormone (hGH)genes were subcloned into the p1017 vector containing
gene.the proximal promoter of p56 lck and the human growth
(B) CrmA is expressed in the thymus of CrmA-transgenic mice.
hormone gene (Chaffin et al., 1990) (Figure 1A). The Western blot of thymocyte (Th) and splenocyte (Sp) lysates from
cloning site places the gene of interest into the 59 un- CrmA-transgenic (CrmA1/2) and wild-type (CrmA2/2) mice using a
translated region of the growth hormone gene. Founder rabbit polyclonal antibody to CrmA (38 kDa). Also included is a
lysate from an EL4 murine T cell clone (E4) transfected with a CrmAlines were screened by Western blotting, and lines that
mammalian expression construct (pb-actinneo-CrmA).expressed high levels of protein in the thymus were bred
(C) FADDdd is expressed in p1017-FADDdd±transgenic mice. West-for testing. As depicted in Figure 1B, there was a high
ern blot of thymocyte (Th), lymph node (LN), and splenocyte (Sp)
level of the CrmA product in thymocytesbut not insplen- lysates from transgenic (FADDdd1/2) and wild-type (FADDdd2/2)
ocytes. For comparison, a stably transfected EL4 clone mice. Two 18 kDa FADDdd bands migrating very closely during
was tested in the same experiment. This is the expected electrophoresis are evident in these types of Western blots, presum-
ably as a result of posttranslational modification of the mutant poly-pattern based on the specificity of the p56lck proximal
peptide. Immunoprecipitation with anti-AU1 mAb revealed a similarpromoter for thymocytes, but not for mature T cells. In
pattern of bands in the FADDdd-transgenic mice only.contrast, the FADDdd transgene product was expressed
in thymocytes, but also at approximately the same lev-
els in splenocytes and lymph node cells. Either the
CD95 cross-linking or dexamethsone treatment to cause
transgene has integrated in the genome in such a way
apoptosis. An early consequence of apoptotic commit-
as to extend the expression of the construct to include
ment in thymocytes is a loss of the mitochondrial inner
mature T cells, or else the transcribed message or the
membrane potential Dcm, a proton gradient across theprotein is stable for an extended period after thymic
inner mitochondrial membrane (Castedo et al., 1995;
emigration. Either way, the transgenic product could be
Petit et al., 1995; Zamzami et al., 1995a). This parameter
expected to affect the phenotype of both developing was assayed by the lipophilic fluorochrome DiOC6(3),
and mature T cells. which fluoresces in the presence of a normal mitochon-
drial proton gradient. As depicted in Figure 2A, the
FADDdd (top graphs) and the CrmA (bottom graphs)Inhibition of Apoptosis by FADDdd
and CrmA Transgenes transgenes were effective in blocking apoptosis medi-
ated by anti-CD95 but not that mediated by dexametha-To test the functional effectiveness of human FADDdd
and CrmA in primary cells, we measured the ability of sone. The level of CD95 expression in the thymocytes
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Figure 3. FADDdd and CrmA Transgenes Inhibit Caspase Activation
(A) Thymocytes from wild-type and CrmA1/2 littermateswere treated
with 2 mg/ml anti-mouse CD95 or 10 nM dexamethasone (Dex) for
18 hr. Lysates from 5 3 106 cell equivalents were loaded into each
lane of a 10% SDS-PAGE gel, electrophoresed, and transferred toFigure 2. FADDdd and CrmA Transgenes Inhibit Anti-CD95±Medi-
nitrocellulose. PARP cleavage was visualized by incubation withated Apoptosis
rabbit polyclonal anti-bovine PARP antibody followed by enhanced(A) A comparison of apoptotic inhibition by FADDdd and CrmA.
chemiluminescence. Uncleaved PARP migrates at118 kDa, whereasApoptosis was measured by flow cytometry using DiOC6(3) to detect
processed PARP migrates at 85 kDa. A small amount of PARPmitochondrial potential after 18 hr in culture. Numbers represent
cleavage was consistently observed in untreated (UnTx) thymocytethe percentage of thymocytes with low levels of DiOC6(3) staining
cultures, likely a consequence of death resulting from thymocyterelative to the entire population.
isolation and ex vivo culture.(B) Comparison of CD95-induced apoptosis inFADDdd and lpr mice.
(B) Time course of caspase activation in FADDdd1/2 mice as mea-As in (A) except for the addition of 10 mg/ml cycloheximide (CHX)
sured by cleavage of the fluorogenic caspase substrate DEVD-AMC.to some cultures. UnTx, untreated.
Thymocytes from FADDdd and wild-type littermates were incubated
for the noted times with 2 mg/ml anti-mouse CD95 or 10 nM dexa-
methasone; following culture, cells were harvested and lysed. Re-
sults are expressed as picomoles of AMC released (relative to aof FADDdd-transgenic mice was normalas measuredby
standard curve of free AMC) per minute of substrate incubation perflow cytometry (data not shown).Additional experiments
milligram protein in the lysate. Untreated thymocytes have basalusing thapsigargan and staurosporine showed that nei-
DEVDase activity for the same reason as described in (A).
ther FADDdd nor CrmA blocks these inducers of apo-
ptosis. In addition, later stages of apoptosis were mea-
sured using annexin V (which measures the exposure the activation of caspases and subsequent cleavage of
a variety of cellular substrates. While CrmA can blockof phosphotidylserine on the surface of the cell), hy-
droethidium (which fluoresces brightly in the presence apoptosis induction by directly interfering with cas-
pases-1 and -8, FADDdd blocks the activation of theseof oxygen radicals produced during apoptosis) (Castedo
et al., 1995; Zamzami et al., 1995b), and TUNEL (TdT- cascades by inhibiting the association of endogenous
FADD with death-domain±containing molecules. It wasmediated dUTP-biotin nick end labeling) analysis of DNA
fragmentation (Gavrieli et al., 1992). The only protection of interest to determine whether these transgenes were
capable of inhibiting the activation of caspase cascadesafforded by either the FADDdd or CrmA transgenes was
from death induced by anti-CD95. With the addition of by measuring the cleavage of known substrates. One
such method is to assay for the cleavage of endogenouscycloheximide such that 100% of wild-type thymocytes
were committedto apoptosis, thymocytes from FADDdd poly(ADP-ribose) polymerase (PARP), a DNA-associat-
ing nuclear protein inactivated by cleavage between itsmice showed no change in mitochondrial potential over
background; this level of inhibition was comparable to DNA-binding and catalytic domains during apoptosis;
this cleavage can be detected in anti-PARP Westernthat afforded by the lpr mutation (Figure 2B). Consistent
with its extended expression pattern, experiments blots as processing of the normally 118 kDa PARP pro-
tein to an 85 kDa cleavage product (Lazebnik et al.,showed that FADDdd inhibited apoptosis in activated
peripheral T cells (data not shown). 1994). As shown in Figure 3A, the CrmA transgene
blocks PARP cleavage induced by anti-CD95 but notAnother early indication of apoptotic commitment is
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Figure 4. FADDdd Transgene Disrupts T Cell
Development
(A) Thymocytes and splenocytes in FADDdd1/2
and FADDdd1/1 are diminished in number
compared to littermates. Thymus and spleen
CD4 versus CD8 populations were analyzed
in 4-week-old littermates. The numbers be-
low the dot plots indicate total thymus cellu-
larity, whereas the numbers in the quadrants
represent the percentage of cells staining in
each gate.
(B) Populations defined by CD25 and CD44
expression were analyzed in DN thymocytes
from FADDdd1/2 and wild-type littermates.
Thymocytes were treated with anti-CD4, anti-
CD8, and complement; washed; and stained
with anti-CD25 and anti-CD44 for analysis.
that induced by dexamethasone. These results demon- et al., 1994; Takahashi et al., 1994). Surprisingly, despite
the profound inhibition of CD95-mediated apoptosis instrate that glucocorticoid activation of apoptosis does
not require caspases-1 and -8, although they do not rule FADDdd mice and the expression of the transgene in
peripheral T cells, we found no indication of lymphopro-out the involvement of other caspases. As a method for
determining the levels of caspase activity present in apo- liferative disease, nor did we observe development of
CD31B2201 population in mice up to 1.5 years of ageptotic extracts, we employed a fluorogenic assay (Fernan-
des-Alnemri et al., 1995) that follows the release of the (data not shown). One explanation for this apparent
enigma is that the FADDdd is not sufficiently effectivefluor aminomethyl coumarin (AMC) from the DEVD (aspar-
tate-glutamate-valine-aspartate) tetrapeptide, the PARP to prevent physiological activation-induced cell death.
A second is that activation of the cascade commencingcleavage site (see Experimental Procedures). As shown
in Figure 3B, incubation of thymocytes with anti-CD95 with caspase-8 may be only part of the signaling activity
mediated by CD95, and other signals are sufficient toleads to rapid activation of DEVD cleavage activity,
whereas DEVD cleavage activity was not detected in mediate apoptosis. A third explanation is that FADDdd
inhibits T cell activation, and thus, even if the cells aresimilarly treated FADDdd1/2 thymocytes. As expected,
glucocorticoid-induced caspase activation occurs with defective for activation-induced cell death, there is no
disregulated lymphoproliferation. These possibilities areslower kinetics and does not require functional FADD.
Similar results were obtained with CrmA thymocytes not mutually exclusive.
(data not shown).
T Cell Development and Selection in FADDdd
and CrmA Transgenic MicePeripheral Expression of FADDdd Does Not
Lead to lpr-Like Lymphadenopathies T cell development in FADDdd- and CrmA-transgenic
mice was analyzed by characterizing thymocytes andDefects in Fas signaling lead to lymphadenopathies first
characterized in Fas-defective mice (Allen et al., 1990; splenocytes for the percentage and total number of cells
in each of the subsets as defined by CD4 and CD8Matsuzawa et al., 1990; Matsuzawa et al., 1991; Wata-
nabe-Fukunaga et al., 1992) and Fas ligand±defective expression (Figure 4A). Thymi from CrmA mice (includ-
ing CrmA1/1 mice) were consistently indistinguishablemice (Shirai et al., 1990; Wadsworth et al., 1990; Lynch
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Figure 5. Negative Selection of Male H2b
Thymocytes by the HY TCR Transgene Is Un-
perturbed by FADDdd and CrmA Transgenes
(A) FADDdd1/2 mice were bred with a trans-
genic mouse carrying the male HY-specific
TCR transgene, and (FADDdd 3 HY TCR) F1
transgenic mice were obtained. Shown are
profiles from 6-week-old littermates; the
number below each dot plot is the number of
thymocytes harvested from each mouse. All
mice shown are MHC homozygous for H-2b.
Gates for CD4 and CD8 SP and DP thymo-
cytes were drawn using thymocytes obtained
from a non-TCR/non-FADDdd littermate (left
dot plot); numbers next to these boxes indi-
cate the percentages of thymocytes in each
population.
(B) CrmA does not block negative selection
in HY-specific TCR transgenic mice. CrmA1/2
mice were bred with an HY TCR-transgenic
mouse and the resulting double-transgenic
thymocytes were harvested and analyzed by
flow cytometry. The thymocytes were har-
vested from 7-week-old littermates.
from those of wild-type littermates, in agreement with for CD25 and CD44. Previous work indicates that there
is a progression from CD441CD252→CD441CD251→previously published results (Smith et al., 1996). In con-
trast, the thymus subsets from FADDdd mice were sub- CD251CD442→CD252CD442 (Godfrey and Zlotnik, 1993;
Godfrey et al., 1994). As shown in Figure 4B, FADDdd1/2stantially altered. Most notably, the total number of cells
in homozygous transgenic mice was approximately 35% mice have an enhanced population of CD251CD442
cells and a paucity of cells in the CD252CD442 popula-that of normal littermates. A compilation of thymus cellu-
larity found in FADDdd1/2 mice by week of age, assaying tion. This staining pattern provides evidence that there
is a partial block in development at the CD251CD442a total of 44 littermates and 46 FADDdd1/2 mice, re-
vealed a decrease consistent with the example pre- stage of development, a stage that corresponds to the
expression of the preTCR±CD3 complex and the initiationsented in Figure 4A (data not shown). This defect was
apparently more profound than revealed by the numbers of thymocyte proliferation (Kisielow and von Boehmer,
1995). This observation appears to account for the di-in the thymus since the number of splenic T cells was
dramatically reduced (as described below). minished thymus found in FADDdd mice. It is unlikely
that this developmental block results from defects inOne possibility for the decreased thymus size is that
signaling through the preTa±TCRb receptor is inhibited, the expression or presentation of the TCR complex,
since normal levels of TCR chains were detected on theand this inhibition could causeboth increased apoptosis
and an inhibition of thymic expansion. Since we did not surface of FADDdd1/1 mice and since TCR transgenes
do not rescue this block (data not shown).see an increase in the number of overtly apoptotic cells
as measured by mitochrondrial potential or DNA frag- To determine whether these transgenic proteins can
cause a defect in thymic negative selection, both typesmentation (TUNEL), the cells do not have the phenotype
of preselection cells found in RAG-2±deficient mice or of transgenic mice were crossed with TCR±transgenic
mice that have incorporated the HY±specific TCR. Thismice with severe combined immunodeficiency (Penit et
al., 1995; Maraskovsky et al., 1997). A caveat is that model of negative selection is manifested by a small
thymus containing almost no double-positive (DP) thy-engulfment of dead cells is extremely efficient, so a
partial inhibition of signaling and the associated in- mocytes (Kisielow et al., 1988). The interpretation is that
deletion occurs at the DN stage or in the transition ofcreased death rate may be difficult to detect (Surh and
Sprent, 1994). thymocytes from DN toDP. As shown in the flow cytome-
try profiles presented in Figures 5A and 5B, neitherIf there is a halt in development that prevents normal
maturation, we might also expect to see abnormal DN FADDdd nor CrmA afforded protection against HY±medi-
ated negative selection as is evidenced by the smallprecursor populations. The thymocytes from FADDdd-
transgenic mice and their littermates were analyzed for number of DP thymocytes in these double-transgenic
animals. In addition, the relative populations of periph-the populations within the CD42CD82 (DN) subset. Thy-
mocytes depleted of CD41 and CD81 cells were stained eral T cells were essentially identical to wild-type (data
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Table 1. Splenic T Cells in FADDdd1/2 and Wild-Type Littermates
Wild-Type FADDdd1/2
Age
(wk) CD4 (%) CD8 (%) n CD4 (%) CD8 (%) n
2 5.8 6 1.6 2.2 6 0.62 3 3.6 6 1.6 1.3 6 0.5a 4
3 11.8 6 1.5 5.9 6 0.5 2 6.6 6 1.1a 2.0 6 1.1a 2
4 8.3 6 2.6 5.2 6 2.2 6 6.2 6 2.2 2.3 6 1.1a 7
5 10.2 6 2.1 4.8 6 1.3 4 8.5 6 2 2.4 6 0.4a 4
6±9 16.2 6 3.5 9.2 6 2.5 4 15 6 3.4 4.2 6 0.7a 3
a Different from wild-type according to Student's t test (p , 0.05).
not shown). Previous work indicates that there is no and an optimal concentration of phorbol myristate ace-
tate (PMA) (Figure 6A). The cells were competent tosingle model of negative selection that serves as an
respond since they proliferated normally in response toindicator of thymic deletion, and future studies will ex-
PMA and ionomycin. The causeof theunresponsivenessamine the role of FADDdd in other models of negative
does not seem to be readily explained by a lack ofselection.
maturity, since FADDdd mice have normal numbers of
CD41CD82HSAlo and CD42CD81HSAlo cells, a pheno-
type indicative of antigen responsiveness (Ramsdell etFADDdd Mice Have a Diminished Population
al., 1991). The defect was seen within a wide dose ofof Peripheral T Cells
anti-CD3 and superoptimal anti-CD28, as shown in theTo determine whether cells that had progressed past
experiment presented in Figure 6B. One interpretationthe CD442CD251 stage went on to complete develop-
is that the FADDdd-transgenic protein blocks the signalment, the peripheral T cell population was analyzed in
transduction that is required for T cell activation. Fur-hemizygous and homozygous transgenic mice. The first
thermore, since CrmA does not have the same effect,readily apparent observation was that in 3- to 4-week-
the signal does not depend on caspase-8 activation,old FADDdd mice there are few splenic T cells and their
but rather it is a distinct signaling cascade that branchesnumber appears to depend on the number of copies of
upstream of activation of caspases-1 and -8. Combinedthe transgene (Figure 4A, right graphs). In these mice,
with the paucity of T cells in the spleens of young mice,the number of T cells ranged from approximately 20%
these data indicate that newly developed T cells arein wild-type mice to 3% in homozygous transgenic mice.
defective for activation and emigration from the thymus.Table 1 provides a compilation of the percentage of T
The proliferative defect found in peripheral T cells
cells in the spleen of FADDdd1/2 mice by age. As shown,
was different. As presented in Figures 6C and 6D, the
there was a significant reduction in the number of T cells
responsiveness to anti-CD3 plus anti-CD28 was not sig-
in hemizygotes, especially CD81 T cells, but we expect
nificantly different from that of littermate controls. How-
that the number of CD41 T cells would become signifi-
ever, the lymph node T cells from FADDdd mice dis-
cant with a larger sample size. In older mice the numbers played a highly abnormal phenotype with respect to
of CD4 T cells in the spleen and lymph nodes rise to other methods of activation. The cells appeared able to
wild-type levels, although the number of CD8 T cells respond to some extent to the addition of PMA alone,
remains low (Table 1 and data not shown). Although we whereas they were reproducibly deficient when acti-
have not examined as many FADDdd homozygous mice, vated in response to anti-CD3 plus PMA or even iono-
there is a consistent and profound deficiency in the CD4 mycin plus PMA (Figure 6C).
and CD8 T cell populations. A similar decrease in mature The ability of the lymph node T cells from FADDdd
T cell populations was not seen in CrmA-transgenicmice mice to be stimulated to divide by the addition of PMA
(data not shown). has not previously been observed, and so it was investi-
gated further. PMA was titrated into cultures of thymus
and lymph node cells from FADDdd mice and wild-type
FADDdd but Not CrmA Inhibits Activation littermates. The results (Figure 6E) revealed that indeed
of T Cells through the TCR and CD28 lymph node T cells undergo proliferation in response
To measure the ability of T cells to be activated through to PMA alone, whereas neither wild-type T cells nor
TCR and coreceptor interactions, thymocytes were thymocytes from FADDdd show the same responsive-
stimulated with various combinations of plate-bound ness. Clearly, there is a dramatic imbalance in thesignal-
anti-CD3 and anti-CD28 antibodies. The responding ing circuitry in thymocytes and T cells from FADDdd
cells in wild-type and FADDdd mice were entirely CD41 mice, and this imbalance is manifested differently in
thymic and lymph node T cells.and CD81 single-positive (SP) cells as assessed by flow
cytometric analysis of the blast cells after activation
(data not shown). In addition, the level of CD3 and CD28 Discussion
expressed on the mature T cells was identical to that
of wild-type littermates (data not shown). Thymocytes To date, work in the field has shown that FADD is an
from FADDdd mice were defective for proliferation when essential adapter between the receptors that possess
a death domainÐCD95, TNFRI, and DR3Ðand caspase-8.stimulated with either anti-CD3 and -CD28 or anti-CD3
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Figure 6. The FADDdd Transgene Alters the
Proliferative Responses of Thymocytes and
Peripheral T Cells
(A) Activation of FADDdd thymocytes. Thy-
mocytes (equalized for 5 3 105 CD4 SP cells/
well) in a 96-well plate were incubated in cul-
ture media alone (Cntl), with 5 ng/well of
plate-bound anti-mouse CD3 (aCD3) with-
out and with superoptimal anti-mouse CD28
(aCD28). In some wells, PMA was added at
1 ng/ml without or with plate-bound anti-CD3
or with 0.1 mg/ml of the calcium ionophore
A23187. Each result represents the mean
counts per minute from an experiment per-
formed in triplicate; error bars represent the
standard deviation from this mean.
(B) Thymocytes from FADDdd mice are de-
fective for anti-CD3 plus anti-CD28 activa-
tion. FADDdd1/2 thymocytes were stimulated
with the indicated amount of plate-bound
anti-mouse CD3 antibody and soluble anti-
CD28 ascites and analyzed as described
above.
(C) Lymph node cells from FADDdd1/2
transgenic are defective in T cell activation.
Lymph node (LN) cells (equalized for 5 3 105
CD4 SP T cells/well) were treated and ana-
lyzed as described in (A).
(D) Peripheral T cells from FADDdd mice do
not show a defect in anti-CD3 plus anti-CD28
activation. Dose dependence of TCR ligation
during activation of LN cells from wild-type
and FADDdd1/2 mice.
(E) Thymocytes and LN cells obtained from
FADDdd1/2 and wild-type mice were cultured
with the indicated concentrations of PMA for
48 hr prior to an 18 hr pulse with [3H]thymi-
dine. Thymocytes and LN cells were added
at a concentration normalized to 5 3 105 CD4
T cells/well. Results represent the mean 3H
counts per minute incorporated during tripli-
cate experiments.
Since this cascade of signaling has been directly shown may occur after TCR b-chain selection. On the other
hand, since preTa±TCRb signals promote expansion, sur-to mediate all of the hallmarks of apoptosis, FADD has
justifiably been implicated as a mediator of activation- vival, and b-chain exclusion (Groettrup and von Boehmer,
1993), it is possible that effects of the FADDdd moleculeinduced cell death (Vincenz and Dixit, 1997). As in all
biological processes such a simplistic explanation ap- are selective. There is a further defect in the ability of
mature thymocytes in these mice to respond throughpears to be insufficient to explain the role of death
domain±containing proteins in the physiology of the im- the TCR and CD28 even though they have a normal
population of mature thymocytes as assessed by TCR,mune system. In this report we show that a dominant-
interfering form of FADD inhibits T cell development and CD4, CD8, and HSA expression. The implication of these
latter results is that there does not seem to be a defectactivation, and these results imply that functional FADD
signaling is essential for normal T cell development and in positive selection and that FADD does not play a role
in this aspect of signaling-mediated maturation. ThisT cell activation.
In FADDdd-transgenic mice there is a defect in the hypothesis was confirmed by analyzing mice that ex-
press FADDdd together with either class I± or classprogression of thymocytes from the CD251CD442 to the
CD252CD442 phenotype that was previously shown to II±specific TCR trangenes. In these mice there were nor-
mal proportions of CD8 or CD4 SP thymocytes, respec-be associated with preTCR expression and p56lck activa-
tion (Anderson et al., 1992; Levin et al., 1993; Godfrey tively. Finally, there was found to be a deficit of T cells
in peripheral lymphoid organs: either mature T cells didet al., 1994). In mice that lack the capacity for TCRb
rearrangement, there is also a block at this stage and not emigrate from the thymus efficiently; or they did not
home efficiently to the spleen; or their rate of survivala large number of apoptotic cells (Penit et al., 1995;
Maraskovsky et al., 1997). We did not find any increase was decreased.Since the lack of T cellswas most severe
in young mice and diminished to some extent with age,in thenumber of apoptotic cells, indicating that the block
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Experimental Procedureswe favor the idea that the cells are inefficiently exported
from thymus. We wish to consider the possibility that
Micein the absence of FADD signaling, only those T cells Mice were generated, bred, and maintained at the University of
that can compensate by becoming hyperresponsive to California, San Diego animal facilities. HY mice are transgenic for
other signals would leave the thymus and populate the TCR a and b chains that confer specificity for the male HY antigen
in the context of MHC class I Db (Kisielow et al., 1988).periphery. This hypothesis is strengthenedby the finding
that, unlike thymocytes, peripheral FADDdd T cells are
Production of p1017-FADDdd and p1017-CrmA±Transgenic Micecapable of normal mitogenic stimulation by anti-TCR
The p1017-FADDdd expression vector was generated by subcloning
and anti-CD28, although they are activated by PMA the AU1-tagged NFD4 truncation of human FADD (amino acids 80±
alone, a signal insufficient to activate normal T cells. It 208) (Chinnaiyan et al., 1995) into the BamHI cloning site of the
is likely that the complete elimination of FADD could p1017 lck proximal promoter murine expression vector. This BamHI
site is flanked at the 59 end by the proximal promoter region of themanifest an even more severe phenotypic deficiency.
murine p56lck gene and at the 39 end by the entire gene encodingOur understanding of the contribution of CD95 activa-
human growth hormone (Chaffin et al., 1990; Sentman et al., 1991;tion in immune development, function, and homeostasis
Swan et al., 1995). This version of FADD is missing the first 80 amino
is far from complete. It is clear that apoptosis mediated acids corresponding to theputative death effector domain proposed
by CD95 contributes a complimentary cytotoxic mecha- to associate with target caspases FLICE (Boldin et al., 1996; Muzio
et al., 1996) and FLICE-2 (Vincenz and Dixit, 1997). The p1017-CrmAnism to that afforded by perforin and granule release
transgene was produced by similarly cloning the entire 1.0 kb openduring cytotoxic T lymphocyte and natural killer cell cy-
reading frame of cowpoxvirus CrmA (Ray et al., 1992) into the p1017totoxicity (Rouvier et al., 1993; Kagi et al., 1994; Kojima
BamHI cloning site. These constructs were prepared by cesium
et al., 1994; Lowin et al., 1994; Walsh et al., 1994a, chloride banding, cut with NotI, and isolated by sucrose gradient
1994b). In addition, CD95-induced apoptosis may also extraction procedures. The isolated fragments were used for micro-
injection of (C57BL/6 3 BALB/c) F1 embryos by the University ofcontrol access of activated T cells to immune privileged
California, San Diego Transgenic Core Facility. Transgenic founderssites (Griffith et al., 1995, 1996). Yet, a putative role in
were identified by Southern analysis of tail DNA, and the resultingtransducing apoptotic signals during thymic selection
founders were backcrossed to C57BL/6 females or intercrossed.
is less clear. Several investigators have found no disrup-
tion in TCR transgene± and endogenous superantigen± Western Analyses
CrmA Western blots were performed using thymocytes and spleno-mediated negative selection in CD95-mutant mice (Kot-
cytes isolated from wild-type and CrmA1/2 littermates. Followingzin et al., 1988; Zhou et al., 1991; Herron et al., 1993;
harvest, 2 3 107 lymphocytes from indicated organs were lysed inSinger and Abbas, 1994; Adachi et al., 1996; Sytwu et al.,
70 ml of 1% Nonidet P-40 lysis buffer (50 mM Tris [pH 7.6], 120 mM
1996). On the other hand, a model of negative selection NaCl, 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 mg/ml leupep-
mediated by in vivo administration of agonistic anti- tin, 1 mg/ml aprotinin) followed by a 20 min high-speed spin in a
TCR antibodies (Shi et al., 1991) has been shown to be microfuge at 48C to remove debris. The supernates were boiled
in SDS loading buffer and run on 12% SDS±polyacrylamide gelblocked in lpr mice (Castro et al., 1996). We have also
electrophoresis (SDS-PAGE). Following electrophoresis, the sam-observed this effect in lpr mice and have noted a similar
ples were transferred to Protran nitrocellulose membranes (Schlei-inhibition of this acute, wholesale thymocyte deletion in cher and Schuell) and blocked by overnight incubation in PBST (13
CrmA mice (data not shown). Since FADDdd, CrmA, phosphate-buffered saline [PBS], 0.1% Tween-20) supplemented
and lpr mice manifest no defect in more physiological with 5% nonfat milk protein (PriceClub brand). For primary incuba-
tion, blots were incubated in a 1:1000 dilution of anti-CrmA rabbitmodels of negative selection, we favor a model in which
polyclonal serum (Tewari and Dixit, 1995) diluted in PBST 1 milkthymocyte negative selection occurs by processes inde-
(PBSTM). Blots were washed three times in PBSTM followed by
pendent of CD95 and the other death domain receptors. incubation with horseradish peroxidase±conjugated goat-anti-rab-
While we set out to test the simple hypothesis that bit antibody (Southern Biotechnology Associates, Birmingham, AL)
thymic negative selectiondependsonFADD asan adapter diluted 1:2500 in PBSTM. Blots were developed using enhanced
chemiluminescence (Amersham).to an apoptosis cascade, we learned instead that FADD-
FADD Western blots were performed in a similar fashion withbinding molecules must have other functions in T cellsÐ
lymphocytes harvested from wild-type and FADDdd1/2 littermates.
functions that are independent of the activation of cas- Following harvest, 2 3 107 lymphocytes from each indicated organ
pase-8. The signal that is inhibited by FADDdd may or were lysed in 1% Triton X-100 lysis buffer (1% Triton, 10 mM Tris
may not come from a death domain±containing recep- [pH 8.0], 150 mM NaCl, and the proteinase inhibitor cocktail listed
above) and electrophoresed on 12% SDS-PAGE. Following separa-tor, although neither T cells from mice bearing the lpr
tion, samples were transferred to nitrocellulose and blocked inmutation (Singer and Abbas, 1994), T cells from CD95-
PBSTM. Blots were incubated in anti-FADD rabbit polyclonal serum
deficient mice (Adachi et al., 1995), T cells from TNFRI- diluted 1:1000 in PBSTM and washed as described above.
deficient mice (Matsumotoet al., 1996; Page et al., 1998), PARP Western blots were performed using whole-cell lysates
nor T cells from CrmA mice (Smith et al., 1996) show isolated from apoptotic thymocyte extracts. Following apoptotic
induction, 5 3 106 thymocytes were resuspended, lysed in 13 PARPthe phenotypic characteristics of the FADDdd mice. The
sample buffer (50 mM Tris [pH 6.8], 6 M urea,6% b-mercaptoethanol,only other receptor known to mediate activity via FADD
3% SDS, 0.003% bromophenol blue), and boiled 5 min prior to
is DR3; however, it is certainly possible that there are loading and electrophoresis through a 10% SDS-PAGE gel. Samples
other FADD-binding receptors that have yet to be dis- were transferred to nitrocellulose, blocked overnight with PBSTM,
and incubated with anti-bovine PARP polyclonal rabbit antiserumcovered. It is possible that FADD mediates its effect on T
422 (Lazebnik et al., 1994) (a kind gift from Guy Poirier) diluted 1:1000cell activation by binding to a nonreceptor, cytoplasmic
in PBSTM.death domain, or even a protein without a death domain.
The present results suggest that there is a novel signal- Flow Cytometry, Antibodies, and CD4 and CD8 Depletions
ing pathway, essential for activation and development Lymphocyte populations were harvested and washed in fluores-
cence-activated cell sorter (FACS) staining buffer (13 PBS, 2% fetalof T cells, that involves FADD.
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calf serum, 0.1% sodium azide) prior to staining with antibodies. Fas-induced apoptosis, the anti-mouse CD95 monoclonal antibody
(mAb) Jo2 (Pharmingen) was added directly to the culture mediaCD4 versus CD8 two-color dot plots were produced by staining
lymphocytes with phycoerythrin-conjugated anti-CD4 and anti- at the concentrations indicated. Glucocorticoid-induced apoptosis
was induced using dexamethasone (Sigma, St. Louis, MO) addedCD8-Tricolor antibodies (Caltag, Burlingame, CA). Staining for CD3
was performed using fluorescein isothiocyanate (FITC)±conjugated to culture media at the indicated concentrations.
anti-CD3 antibodies (Pharmingen, La Jolla, CA). Similarly, staining
for the HY TCR was performed using FITC-conjugated anti-Vb8 Proliferation Assays
antibodies (Pharmingen). Thymocytes and lymph node cells were stained using anti-CD4 and
To analyze double-negative (DN) thymocytes, thymocytes were anti-CD8 antibodies to normalize the numbers of T cells in each
depleted of CD41 and CD81 cells by incubation with rat antibodies culture. Cells equivalent to 5 3 105 CD41 cells in 200 ml of supple-
to murine CD4 and CD8 (RL172.4 and 3.168.36, respectively) along mented EHAA (see above) were added to each well of culture-
with rabbit complement diluted 1:10 (Accurate Chemical and Scien- treated flat-bottomed 96-well plates (Costar). Anti-CD3 was plate
tific, Westbury, NY). Following a 30 min incubation with antibodies bound by adding goat-anti-hamster antibody (Southern Biotechnol-
and complement at 378C, cells were pelleted to remove debris, and ogy Associates) in a carbonate buffer (pH 9.5) at a 1:100 dilution;
aliquots analyzed by flow cytometry (Caltag) to ensure complete following a wash to remove unbound goat-anti-hamster, the anti-
depletion of CD41 and CD81 cell populations. The cells were then mouse CD3 mAb 2C11 was added at a concentration of 5 ng/ml
stained with biotinylated anti-CD25 (Pharmingen), followed by strep- (unless otherwise indicated), incubated for 1 hr at 378C, and washed
tavidin±phycoerythrin. Finally, cells were washed again and stained to remove unbound 2C11. In some wells, soluble anti-mouse CD28
with FITC-conjugated anti-CD44 (Pharmingen). hybridoma supernate (Gross et al., 1992) was added at a dilution of
Analysis of early apoptotic events was performed using the lipo- 1:2 3 105. PMA (Calbiochem, San Diego, CA) was added to specified
philic/cationic dye DiOC6(3) as described (Castedo et al., 1995; Petit cultures at a final concentration of 1 ng/ml, unless indicated other-
et al., 1995). DiOC6(3) (Molecular Probes, Eugene, OR) was diluted wise. The calcium ionophore A23187 (Sigma) was added to cultures
to 40 nM in FACS staining buffer (along with anti-CD4-phycoerythrin at a final concentration of 0.1 mg/ml. Cultures were incubated at
and anti-CD8-FITC). Thymocytes (1 3 106) were incubated in 100 378C for 48 hr and then pulsed for 18 hr with 1 mCi of [3H]thymidine
ml of this cocktail for 15 min at 378C, washed once in FACS buffer, (6.7 Ci/mmol; New England Nuclear, Wilmington, DE). Cultures were
and analyzed by flow cytometry. Events were collected on a FACS- harvested and analyzed with a plate-reading scintillation counter
can flow cytometer (Becton-Dickinson, Palo Alto, CA) and analyzed with aqueous scintillation fluid. Counts displayed represent the
using CellQuest software. All data represent events electronically mean of triplicate values for each experimental condition.
gated in forward and side scatter to remove spurious events, dead
cells, and nonlymphocytes.
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